Упрощенная HTML-версия
277
162.
Resolution of infectious parameters after antimicrobial therapy in patients with
ventilator-associated pneumonia / P.J. Dennesen [et al.] // Am. J. Respir. Crit. Care
Med. – 2001. – Vol. 163 (6). – P. 1371-1374.
163.
Dries D.J. Interferon-[gamma] : Titration of inflammation / D.J. Dies, J.F.
Perry // Crit. Care Med. – 2002. – Vol. 30 (7). – P. 1663-1664.
164.
Dziedzic T. Nosocomial infections and immunity: lesson from drain-ingured
patients / T. Dziedzic, A. Slowik, A. Szczudik // Critical Care. – 2004. – Vol. 8, №
4. – P. 266-270.
165.
Ebong S.J. Critical role of CD14 for production of proinflammatory cytokines
and cytokine inhibitors during sepsis with failure to alter morbidity or mortality / S.J.
Ebong, S.M. Goyert, J.A. Nemzek, J. Kim, G.L. Bolgos, D.G. Remick // Infection
and Immunity. – 2001. – P. 2099-2106.
166.
Echchannaoui H. CD14 deficiency leads to increased MIP-2 production,
CXCR2 expression, neutrophil transmigration, and early death in pneumococcal
infection / H. Echchannaoui, K. Frei, M. Letiembre, R.M. Strieter, Y. Adachi, R.
Landmann // J. Leukoc. Biol. – 2005. – Vol. 78. – P. 705-715.
167.
Acinetobacter pneumonia: is the outcome different from the pneumonias
caused by other agents / E.C. Edis [et al.] // Ann. Thorac. Med. – 2010. – Vol. 5 (2).
– P. 92-96.
168.
Eng H.-L. Association of CD14 promoter gene polymorphism and Chlamydia
pneumoniae infection / H.-L. Eng, C.-H. Chen, C.-C. Kuo, J.-S. Wu, C.-H. Wang, T.-
M. Lia // J. Infect. Dis. – 2003. – Vol. 188. – P. 90-97.
169.
Eng H.-L. A CD14 promoter polymorphism is associated with CD14
expression and Chlamydia - stimulated TNF alpha production / H.-L. Eng, C.-H.
Wang, C.-H. Chen, M.-H. Chou, C.-T. Cheng, T.-M. Lin // Genes. Immun. – 2004. –
Vol. 5. – P. 426-430.
170.
Polymorphisms in the interleukin-1 gene cluster in children and young adults
with systemic meningococcemia / G. Endler [et al.] // Clinical Chemistry. – 2006. –
Vol. 52 (3). – P. 511-514.